Report DMCA Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.